Related Experiment Video
Updated: Aug 8, 2026

Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
Adverse effects of calcium binding contrast agents in diagnostic cardiac angiography. A comparison between
W H Matthai1, W C Groh, H L Waxman
1Department of Medicine, UMDNJ/Robert Wood Johnson Medical School, Camden, USA.
Insights
Formulations of diatrizoate that bind calcium were associated with more complications during cardiac angiography. Minimizing calcium binding in contrast media may reduce adverse effects on heart function and conduction.
Area of Science:
- Cardiovascular Medicine
- Radiology
- Pharmacology
Background:
- Diagnostic cardiac angiography utilizes contrast media to visualize heart structures.
- Different formulations of diatrizoate contrast media exist, with varying effects on calcium binding.
Purpose of the Study:
- To compare the complications and hemodynamic/electrophysiologic effects of two diatrizoate formulations in cardiac angiography.
- To assess the impact of calcium-binding additives in contrast media.
Main Methods:
- A randomized trial involving 223 low-risk patients undergoing cardiac angiography.
- Patients received either Hypaque 76 (minimal calcium binding) or MD 76 (significant calcium binding).
- Electrocardiographic, hemodynamic parameters, and complications were recorded.
Main Results:
- A higher incidence of complications occurred in the group receiving MD 76 (18 vs. 8).
- Greater decreases in arterial pressure, increased QT interval, and reduced heart rate were observed in the MD 76 group.
- These effects were noted after coronary angiography and left ventriculography.
Conclusions:
- Contrast media formulations that minimize calcium binding are recommended for cardiac angiography.
- Calcium binding by contrast media can adversely affect myocardial function and cardiac conduction.
- Reducing calcium binding may lower the complication rate in high-osmolality contrast media use.
Rationale And Objectives:
The authors compared complications and hemodynamic and electrophysiologic effects of two formulations of diatrizoate, one with additives that bind calcium and one without, in diagnostic cardiac angiography.
Methods:
Two hundred twenty-three consecutive low-risk patients alternately received Hypaque 76 (group 1, little calcium binding effect), and MD 76 (group 2, significant calcium binding). Electrocardiographic and hemodynamic changes related to coronary angiography and left ventriculography were measured, and complications requiring treatment were recorded.
Results:
There were more complications in patients in group 2 than in group 1 (18 versus 8, P = 0.04). Arterial pressure fell more, the QT interval increased more, and the heart rate fell more in group 2 after coronary angiography.
Conclusions:
Formulations of diatrizoate that minimize calcium binding are advocated for cardiac angiography when using high osmolality contrast media. The more detrimental effects that calcium binding has on myocardial function and cardiac conduction may lead to the higher incidence of complications.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies III: Computed Tomography

